For example, one possible way to reduce tau endocytosis and subsequent spreading of tau pathology may be to decrease neuronal levels of BIN1 and PICALM (which are increased in Alzheimer's disease) in early stages of the disease. The gene discussed is MAPT; the disease is Alzheimer disease.